1058 related articles for article (PubMed ID: 27615397)
1. Autoantibody Signature Enhances the Positive Predictive Power of Computed Tomography and Nodule-Based Risk Models for Detection of Lung Cancer.
Massion PP; Healey GF; Peek LJ; Fredericks L; Sewell HF; Murray A; Robertson JF
J Thorac Oncol; 2017 Mar; 12(3):578-584. PubMed ID: 27615397
[TBL] [Abstract][Full Text] [Related]
2. Combining serum miRNAs, CEA, and CYFRA21-1 with imaging and clinical features to distinguish benign and malignant pulmonary nodules: a pilot study : Xianfeng Li et al.: Combining biomarker, imaging, and clinical features to distinguish pulmonary nodules.
Li X; Zhang Q; Jin X; Cao L
World J Surg Oncol; 2017 May; 15(1):107. PubMed ID: 28545454
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a plasma biomarker panel for discerning clinical significance of indeterminate pulmonary nodules.
Daly S; Rinewalt D; Fhied C; Basu S; Mahon B; Liptay MJ; Hong E; Chmielewski G; Yoder MA; Shah PN; Edell ES; Maldonado F; Bungum AO; Borgia JA
J Thorac Oncol; 2013 Jan; 8(1):31-6. PubMed ID: 23201823
[TBL] [Abstract][Full Text] [Related]
4. Distinguishing patients with stage I lung cancer versus control individuals using serum mass profiling.
Hanas JS; Peyton MD; Lerner MR; Lightfoot SA; Deb SJ; Hanas RJ; Vu NT; Kupiec TC; Stowell DE; Brackett DJ; Dubinett SM; Hocker JR
Cancer Invest; 2014 May; 32(4):136-43. PubMed ID: 24579933
[TBL] [Abstract][Full Text] [Related]
5. A Gene Expression Classifier from Whole Blood Distinguishes Benign from Malignant Lung Nodules Detected by Low-Dose CT.
Kossenkov AV; Qureshi R; Dawany NB; Wickramasinghe J; Liu Q; Majumdar RS; Chang C; Widura S; Kumar T; Horng WH; Konnisto E; Criner G; Tsay JJ; Pass H; Yendamuri S; Vachani A; Bauer T; Nam B; Rom WN; Showe MK; Showe LC
Cancer Res; 2019 Jan; 79(1):263-273. PubMed ID: 30487137
[TBL] [Abstract][Full Text] [Related]
6. Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial.
Walter JE; Heuvelmans MA; de Jong PA; Vliegenthart R; van Ooijen PMA; Peters RB; Ten Haaf K; Yousaf-Khan U; van der Aalst CM; de Bock GH; Mali W; Groen HJM; de Koning HJ; Oudkerk M
Lancet Oncol; 2016 Jul; 17(7):907-916. PubMed ID: 27283862
[TBL] [Abstract][Full Text] [Related]
7. Estimation of malignancy of pulmonary nodules at CT scans: Effect of computer-aided diagnosis on diagnostic performance of radiologists.
Liu J; Zhao L; Han X; Ji H; Liu L; He W
Asia Pac J Clin Oncol; 2021 Jun; 17(3):216-221. PubMed ID: 32757455
[TBL] [Abstract][Full Text] [Related]
8. Assessment of indeterminate pulmonary nodules detected in lung cancer screening: Diagnostic accuracy of FDG PET/CT.
Garcia-Velloso MJ; Bastarrika G; de-Torres JP; Lozano MD; Sanchez-Salcedo P; Sancho L; Nuñez-Cordoba JM; Campo A; Alcaide AB; Torre W; Richter JA; Zulueta JJ
Lung Cancer; 2016 Jul; 97():81-6. PubMed ID: 27237032
[TBL] [Abstract][Full Text] [Related]
9. A model based on the quantification of complement C4c, CYFRA 21-1 and CRP exhibits high specificity for the early diagnosis of lung cancer.
Ajona D; Remirez A; Sainz C; Bertolo C; Gonzalez A; Varo N; Lozano MD; Zulueta JJ; Mesa-Guzman M; C Martin A; Perez-Palacios R; Perez-Gracia JL; Massion PP; Montuenga LM; Pio R
Transl Res; 2021 Jul; 233():77-91. PubMed ID: 33618009
[TBL] [Abstract][Full Text] [Related]
10. Predicting Malignancy Risk of Screen-Detected Lung Nodules-Mean Diameter or Volume.
Tammemagi M; Ritchie AJ; Atkar-Khattra S; Dougherty B; Sanghera C; Mayo JR; Yuan R; Manos D; McWilliams AM; Schmidt H; Gingras M; Pasian S; Stewart L; Tsai S; Seely JM; Burrowes P; Bhatia R; Haider EA; Boylan C; Jacobs C; van Ginneken B; Tsao MS; Lam S;
J Thorac Oncol; 2019 Feb; 14(2):203-211. PubMed ID: 30368011
[TBL] [Abstract][Full Text] [Related]
11. Relationship between nodule count and lung cancer probability in baseline CT lung cancer screening: The NELSON study.
Heuvelmans MA; Walter JE; Peters RB; Bock GH; Yousaf-Khan U; Aalst CMV; Groen HJM; Nackaerts K; Ooijen PMV; Koning HJ; Oudkerk M; Vliegenthart R
Lung Cancer; 2017 Nov; 113():45-50. PubMed ID: 29110848
[TBL] [Abstract][Full Text] [Related]
12. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening.
Horeweg N; van Rosmalen J; Heuvelmans MA; van der Aalst CM; Vliegenthart R; Scholten ET; ten Haaf K; Nackaerts K; Lammers JW; Weenink C; Groen HJ; van Ooijen P; de Jong PA; de Bock GH; Mali W; de Koning HJ; Oudkerk M
Lancet Oncol; 2014 Nov; 15(12):1332-41. PubMed ID: 25282285
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Prediction Models for Identifying Malignancy in Pulmonary Nodules Detected via Low-Dose Computed Tomography.
González Maldonado S; Delorme S; Hüsing A; Motsch E; Kauczor HU; Heussel CP; Kaaks R
JAMA Netw Open; 2020 Feb; 3(2):e1921221. PubMed ID: 32058555
[TBL] [Abstract][Full Text] [Related]
14. Audit of the autoantibody test, EarlyCDT®-lung, in 1600 patients: an evaluation of its performance in routine clinical practice.
Jett JR; Peek LJ; Fredericks L; Jewell W; Pingleton WW; Robertson JF
Lung Cancer; 2014 Jan; 83(1):51-5. PubMed ID: 24268382
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of pulmonary nodules detected on abdominal CT in pediatric patients.
Breen M; Zurakowski D; Lee EY
Pediatr Radiol; 2015 Nov; 45(12):1753-60. PubMed ID: 26164441
[TBL] [Abstract][Full Text] [Related]
16. Ability of low-dose helical CT to distinguish between benign and malignant noncalcified lung nodules.
Markowitz SB; Miller A; Miller J; Manowitz A; Kieding S; Sider L; Morabia A
Chest; 2007 Apr; 131(4):1028-34. PubMed ID: 17426206
[TBL] [Abstract][Full Text] [Related]
17. Projected outcomes using different nodule sizes to define a positive CT lung cancer screening examination.
Gierada DS; Pinsky P; Nath H; Chiles C; Duan F; Aberle DR
J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25326638
[TBL] [Abstract][Full Text] [Related]
18. Can spectral computed tomography imaging improve the differentiation between malignant and benign pulmonary lesions manifesting as solitary pure ground glass, mixed ground glass, and solid nodules?
Chen ML; Li XT; Wei YY; Qi LP; Sun YS
Thorac Cancer; 2019 Feb; 10(2):234-242. PubMed ID: 30582292
[TBL] [Abstract][Full Text] [Related]
19. Physician Assessment of Pretest Probability of Malignancy and Adherence With Guidelines for Pulmonary Nodule Evaluation.
Tanner NT; Porter A; Gould MK; Li XJ; Vachani A; Silvestri GA
Chest; 2017 Aug; 152(2):263-270. PubMed ID: 28115167
[TBL] [Abstract][Full Text] [Related]
20. Overestimated value of (18)F-FDG PET/CT to diagnose pulmonary nodules: Analysis of 298 patients.
Li S; Zhao B; Wang X; Yu J; Yan S; Lv C; Yang Y
Clin Radiol; 2014 Aug; 69(8):e352-7. PubMed ID: 24877581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
